GO
Loading...

Enter multiple symbols separated by commas

More Drugs, Profits in Pipeline at Pfizer

Pfizer , the world's largest drugmaker, has raised its earnings guidance for the year and promised a number of late stage products out of its pipeline in the coming years.

The company raised its adjusted earnings-per-share forecast to a minimum of $2.05, from an earlier forecast of $2. Without adjustments, the company expects earnings at least $1.68 per share.

The company cited favorable revenue trends and lower costs.

Analysts surveyed by Thomson Financial expect earnings per share of $2.02.

The outlook follows Pfizer's announcement Tuesday it would cut 20 percent from its U.S. sales force, or 2,200 jobs.

Pfizer stuck to targeting average adjusted earnings per share growth in the high single digits in 2007 and 2008, from its $2.05-per-share estimate for 2006.

The company expects its late-stage product pipeline to grow dramatically or perhaps even triple from 2006 to 2009. This would give the company four new products a year starting in 2011. Areas of concentration include cardiovascular, metabolic and endocrine diseases focusing on atherosclerosis, obesity, diabetes, bone and muscle health, and blood clots.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • Cramer: Here's a sign the market could rally

    Wall Street's been soaking in red, but "Mad Money" host Jim Cramer has one signal to watch for that could point to another run.

  • Burger war maneuvers

    Cramer looks at the number of company's selling burgers and tries to determine the quality names, as well as those to avoid.

  • Cramer: What's driving defense?

    Cramer says that even though President Obama has made it clear the US can no longer be the world's policeman, the country can become the world's arms dealer. Profiting from defense spending.